Becker's Healthcare May 15, 2019
CNBC released the latest edition of its annual Disruptor 50 list on May 15, including several health and biotech startups among its ranking of private companies “whose innovations are changing the world.”
The list was compiled by an advisory council of leaders in innovation and entrepreneurship who ranked the quantitative data of more than 1,200 nominated startups. Together, the 50 companies in the 2019 ranking have amassed more than $46 billion in venture capital, with a total market valuation of $266 billion.
Here are the nine health IT companies classified by CNBC as “disruptors” in their fields.
6. GoodRx (valuation: $2.8 billion): enables consumers to find and compare prescription prices at nearby pharmacies.
19. Ginkgo Bioworks (valuation: $1.4 billion): uses...
Today's Sponsors
Today's Sponsor